•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Sarepta Therapeutics Set to Join S&P MidCap 400
Charles Schwab Investment Management Inc. Grows Position in Shockwave Medical, Inc. (NASDAQ:SWAV)
J&J's $13 billion bid for Shockwave turns to Wall Street for funding
SHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAV
Shockwave Medical (SWAV) Q1 Earnings Beat, Revenues Rise Y/Y
Shockwave Medical (SWAV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Shockwave Medical (SWAV) Q1 Earnings and Revenues Top Estimates
Shockwave Medical Reports First Quarter 2024 Financial Results
Shockwave Medical (SWAV) Earnings Expected to Grow: What to Know Ahead of Q1 Release
Why the Market Dipped But Shockwave Medical (SWAV) Gained Today
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Shockwave Medical (SWAV) Advances While Market Declines: Some Information for Investors
Why Shockwave Medical (SWAV) Could Beat Earnings Estimates Again
Top 5 Non-Tech Nasdaq Winners of Q1 With More Upside Left
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, AIRC, INRD
INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Shockwave Medical, Inc. - SWAV
Shockwave Medical's (SWAV) Reducer Receives Positive Results
SHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAV
Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World' Study
Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.